Advanced Search

Gilead Sciences Stocks List

Symbol Grade Name % Change
GILD C Gilead Sciences, Inc. 0.63
HEPA F Hepion Pharmaceuticals, Inc. 2.92
HOOK C HOOKIPA Pharma Inc. 1.28
NRIX F Nurix Therapeutics, Inc. 12.91
HGEN F Humanigen, Inc. 1.12
View As Page of Charts
Related Industries: Biotechnology Drug Manufacturers - Major
Related Stock Lists: Biopharmaceutical Biotechnology Cancer Cancers Coronavirus Hepatitis B Hepatotoxins Immunodeficiency Infection Infectious Diseases Life Sciences Liver Disease Lymphoma Medicine Tenofovir Disoproxil Transplantation Treatment Of Cancer Angina Antibiotic Bruton

Related ETFs - A few ETFs which own one or more of the above listed Gilead Sciences stocks.

Symbol Grade Name Weight
DWSH F AdvisorShares Dorsey Wright Short ETF 37.4
BIS D ProShares UltraShort Nasdaq Biotechnology 7.41
IBB D iShares Nasdaq Biotechnology Index Fund 7.05
PJP D PowerShares Dynamic Pharmaceuticals 5.47
BIB D ProShares Ultra Nasdaq Biotechnology 5.36
View all Gilead Sciences related ETFs...
Compare ETFs
  • Compare DWSH to BIB
  • Compare DWSH to BIS
  • Compare DWSH to IBB

    • Recent Signals

    Date Stock Signal Type
    2021-04-14 GILD Crossed Above 20 DMA Bullish
    2021-04-14 GILD Crossed Above 200 DMA Bullish
    2021-04-14 GILD Bollinger Band Squeeze Range Contraction
    2021-04-14 HGEN Stochastic Reached Oversold Weakness
    2021-04-14 HGEN Narrow Range Bar Range Contraction
    2021-04-14 HGEN Spinning Top Other
    2021-04-14 HOOK Crossed Above 50 DMA Bullish
    2021-04-14 NRIX 20 DMA Resistance Bearish
    2021-04-14 NRIX Pocket Pivot Bullish Swing Setup

    Recent News for Gilead Sciences Stocks

    Date Stock Title
    Apr 14 GILD Vaccine transparency is ‘the best course of action’: Doctor 
    Apr 14 GILD U.S. in unique position to force increased accountability at the WHO: FDD
    Apr 14 NRIX Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2021
    Apr 14 GILD Gilead (GILD) Gets FDA Nod for Trodelvy in Urothelial Cancer
    Apr 14 GILD Gilead’s Bladder Cancer Drug Trodelvy Gets FDA Nod
    Apr 14 HOOK HOOKIPA Pharma to Present at Kempen Life Science Conference
    Apr 14 GILD A Peek Into The Markets: US Stock Futures Edge Higher; Bank Earnings In Focus
    Apr 13 GILD U.S. FDA Grants Accelerated Approval to Trodelvy® for the Treatment of Metastatic Urothelial Cancer
    Apr 13 NRIX Nurix Therapeutics EPS misses by $0.20, misses on revenue
    Apr 13 NRIX Nurix Therapeutics Reports First Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
    Apr 13 GILD Gilead wins FDA accelerated approval for Trodelvy in urothelial cancer
    Apr 13 GILD How COVID-19 transformed the biotech industry
    Apr 13 GILD Gilead halts remdesivir trial in high-risk COVID-19 patients
    Apr 10 HOOK HOOKIPA announces positive preliminary Phase 1 immunogenicity data for its immunotherapy candidates to treat advanced HPV16+ cancers
    Apr 9 GILD Pfizer’s vaccine EUA expansion request is ‘extremely welcomed’: Doctor
    Apr 9 HGEN Humanigen's Ifabotuzumab Shows Encouraging Action In Early-Stage Brain Cancer Study
    Apr 9 HGEN Humanigen Announces Positive Results From Phase 1 Study of Ifabotuzumab in Glioblastoma Multiforme
    Apr 9 HGEN Is the Options Market Predicting a Spike in Humanigen (HGEN) Stock?
    Apr 9 HGEN Humanigen to present positive Phase 1 data for brain cancer therapy at AACR meeting
    Apr 8 GILD Biotech Stocks Could Use A Win — Will The First Quarter Offer That?
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Biopharmaceutical Biotechnology Cancer Cancers Coronavirus Hepatitis B Hepatotoxins Immunodeficiency Infection Infectious Diseases Life Sciences Liver Disease Lymphoma Medicine Tenofovir Disoproxil Transplantation Treatment Of Cancer Angina Antibiotic Bruton

    Gilead Sciences, Inc. , is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
    Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.

    More about Gilead Sciences
    Browse All Tags